Alcon, Allergan argue FDA pre-emption in defense against class-action suits.
This article was originally published in The Tan Sheet
Executive Summary
ALCON, ALLERGAN PRE-EMPTION DEFENSE IN CONTACT LENS SOLUTION LAWSUITS will be argued in hearings set for June 7 in the case of Nicholas v. Alcon and June 14 in Bruno v. Allergan. The two manufacturers will assert at the hearings in California Superior Court in San Diego that federal device law pre-empts the plaintiffs' claims of false advertising and unfair business practices.